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-7/del(7q) is a more common entity of blood 
malignancies in the adults. 
 
del(7q) G- banding - Courtesy Jean-Luc Lai and Alain 
Vanderhaegen. 
Clinics and pathology 
Disease 
Myelodysplastic syndromes (MDS) and acute non 
lymphocytic leukemia (ANLL); may occur: 
1- de novo,  
2- be secondary to treatments with alkylating agents, or  
3- in patients with predisposing leukemia syndromes: 
Fanconi anemia, Kostmann syndrome, Shwachman-
Diamond syndrome, Neurofibromatosis type I,Down 
syndrome, familial monosomy 7. 
Phenotype/cell stem origin 
MDS cases : more often RAEB/RAEB-T, CMML, or 
the following specific childhood presentations : 
juvenile chronic leukemia (JCML), and monosomy 7 
syndrome; ANLL most often M4 or M6. 
Epidemiology 
the most frequent abnormality in childhood myeloid 
disorders; found in 30% of the MDS and in 4% of the
ANLL; sex/age: 90% of the children with this anomaly 
are younger than 5 years; before 5 years, there is a 
majority of boys (3M/2F), with -7 as the sole 
cytogenetic abnormality; after 5 years, girls are in 
majority, and the -7/del(7q) is then often associated 
with additional anomalies. 
Clinics 
Several clinical forms: the most frequents are JCML 
and the monosomy 7 syndrome; these disorders have 
some common features: 
- JCML is defined by clinical and cytological 
observations; 6 to 24% of JCML  
- children show monosomy 7 in the bone marrow; 
- monosomy 7 syndrome is a cytogenetic-defined 
entity. 
The therapy related cases of monosomy 7 had been 
exposed to alkylating agents, they have a 
myelodysplastic phase preceding acute leukemia with
multilineage bone marrow dysplasia. In opposite, 
therapy including anti-topoisomerase drug induce 
myelodysplastic syndromes and leukemias with 11q23 
abnormalities 
Cytology 
Before 5 years, the disease presents as a specific 
myeloid leukemia characterized by leucocytosis with 
monocytosis but thrombopenia, anemia in blood and 
hyperplasia of the bone marrow; for some authors, the 
diagnosis of monosomy 7 syndrome should be made in 
any FAB class (principally CMML), whereas the 
diagnosis of JCML applies to cases of CMML with 
fetal hemoglobin > 10 %,and with no monosomy 7; the 
remaining CMML are diagnosed as CMML; for others,  
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a - 7 does not exclude the diagnosis of JCML; however, 
cases of JCML without visible monosomy 7 appear to 
have no loss of heterozygosity on chromosome 7. 
After 5 years, the disease presents as a MDS with 
cytopenia in blood and hypodysplasia of bone marrow, 
like in adults. 
Prognosis 
Slow evolution of the ANLL in infants before 6 month; 
for children older than 1 year, the survival is less than 2 
years; the European Working Group on MDS in 
Childhood noted a superior survival for children with 
MDS having a - 7 alone than for those with other 
anomalies (3 year survival of 56% vs 24%); but this 
was the reverse in children with ANLL. 
Cytogenetics 
Cytogenetics morphological 
Deletion (7q): cluster of breakpoints in 7q11 to 7q36, is 
a with two common minimal zones in q22 and in q32-
34. 
Cytogenetics molecular 
Using loss of heterogygocity (LOH) studies and YAC 
libraries, a 2 to 3 Mb segment in 7q22 has been 
designated as the proximal common deleted area; the 
7q33-34 zone is the consensual area for the distal 
deletion; LOH studies suggest that a specific 
mechanism, such as mitotic recombination in bone 
marrow stem cell leading to homozygosity in both 
granulocytes and lymphocytes, may be implicated. 
Probes 
Chromosomal band 7q221: marker D7S658, through 
D7S2494, YAC HSC7E441 to HSC7E572; 7q33-34: 
D7S498 to D7S505; near-centromeric probes of 
chromosome 7 and 7q31 probes are produced by 
commercial companies. 
Additional anomalies 
7 alone is observed in 75% of MDS cases and in 32% 
of ANLL; the specific additional anomalies are -
5/del(5q), and trisomy 8. 
Variants 
The balanced translocation t(1;7)(q10;p10), and many 
unbalanced translocation, having for consequence a 
partial monosomy 7 of the 7q22 to 7q34 bands may, in 
a way, be considered as variants. 
Genes involved and proteins 
Note 
-7/del(7q) is frequent in secondary MDS or ANLL, and 
also in leukemias occurring in individuals with 
constitutional syndromes including predisposition to 
myeloid disorders; these findings suggest the presence 
of a putative myeloid leukemia suppressor gene in the 
commonly deleted genomic segment 7q22 and even 
multiple genes in 7q22 -31.1 that are playing a role in 
 
leukemogenesis; candidate genes are : ASNS 
(asparagine synthetase gene) in 7q21.3-q22.1; ACHE 
(acetyl cholinesterase), EPO (erythropoietin), PLANH1 
(plasminogen activator inhibitor 1) in 7q22; and MET 
in 7q31.2-31.3. 
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